Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2070]

Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC

Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA

Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC ( Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA )

Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma

Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA

Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA )

Ten years of letrozole improves survival and quality of life in early-diagnosed...

Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada

Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer. ( Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada )

Daratumumab slows progression in refractory multiple myeloma

Prof Palumbo - University of Turin, Turin, Italy

$Daratumumab slows progression in refractory multiple myeloma ( Prof Palumbo - University of Turin, Turin, Italy )$

Recent developments in targeted therapies

Dr Stephen Nimer - University of Miami, Miami, USA

Recent developments in targeted therapies ( Dr Stephen Nimer - University of Miami, Miami, USA )

First results of a prospective bendamustine/rituximab trial in patients with MCL

Dr Mathias Rummel - University of Giessen, Giessen, Germany

First results of a prospective bendamustine/rituximab trial in patients with MCL ( Dr Mathias Rummel - University of Giessen, Giessen, Germany )

MyPathway guidance of targeted therapy based on molecular profiles

Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA

MyPathway guidance of targeted therapy based on molecular profiles ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )

Upfront autologous stem cell transplantation for newly diagnosed multiple...

Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy

Upfront autologous stem cell transplantation for newly diagnosed multiple myeloma ( Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy )

Advanced RET-rearranged NSCLC

Dr Takashi Seto and Dr Kiyotaka Yoh

Advanced RET-rearranged NSCLC ( Dr Takashi Seto and Dr Kiyotaka Yoh )

Update on olaparib in ovarian cancer

Prof Jonathan Ledermann - University College Hospital Medical School, London, UK

Update on olaparib in ovarian cancer ( Prof Jonathan Ledermann - University College Hospital Medical School, London, UK )

First in-human trials of rovalpituzumab for SCLC

Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York, USA

First in-human trials of rovalpituzumab for SCLC ( Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York, USA )

Impact of precision medicine in refractory malignancies

Prof Maria Schwaederle - University of California, San Diego, USA

$Impact of precision medicine in refractory malignancies ( Prof Maria Schwaederle - University of California, San Diego, USA )$

More from ecancer